- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Cluster of Differentiation 7 (CD7) is a transmembrane glycoprotein (CD7) expressed on T lymphocytes and natural killer (NK) cells, where it contributes to immune signaling, activation, and effector function. CD7 Antibody / Cytotoxic Lymphocyte Marker Antibody is uniquely positioned for studying cytotoxic immune cell populations, enabling detection of CD7 in effector T cells and NK cells that mediate immune defense against infected, stressed, or malignant target cells.
CD7 antibody, also referred to as T-cell antigen CD7 antibody, is expressed on cytotoxic lymphocyte populations that play central roles in immune surveillance and host defense. These include CD8-positive cytotoxic T cells and NK cells, both of which are responsible for identifying and eliminating target cells through direct cytotoxic mechanisms. CD7 expression supports identification and characterization of these effector populations within complex immune environments.
This CD7 Antibody is uniquely positioned for cytotoxic lymphocyte research, where detection of CD7 enables analysis of effector cell distribution, activation, and functional status. It supports studies investigating how cytotoxic lymphocytes respond to infection, tumor development, and immune challenges, providing insight into the mechanisms that drive immune-mediated cell killing.
In cytotoxic immune responses, CD7-positive cells participate in target cell elimination through pathways involving perforin and granzyme release, as well as through cytokine-mediated signaling that amplifies immune responses. The ability to detect CD7 allows researchers to study these processes at the cellular level and to examine how effector functions are regulated under different experimental conditions.
CD7 is often used in combination with markers such as CD8, CD56, and other cytotoxicity-associated proteins to define functional subsets of cytotoxic lymphocytes. This enables detailed analysis of immune cell heterogeneity, including differences in activation state, effector capacity, and regulatory interactions within the immune system.
The expression of CD7 on both T cells and NK cells highlights its role in bridging adaptive and innate immune responses, making it particularly valuable for studies examining coordinated immune defense mechanisms. This dual relevance supports investigations into how different immune compartments interact to achieve effective pathogen clearance and tumor control.
In addition to its role in normal immune function, cytotoxic lymphocyte activity is often altered in disease states such as cancer, chronic infection, and immune dysregulation. CD7 detection provides a means to study these changes and to investigate how effector cell populations are impacted under pathological conditions.
CD7 Antibody (clone CD7/7605) as a Cytotoxic Lymphocyte Marker Antibody provides a powerful and biologically meaningful tool for investigating effector immune cell biology, enabling detailed analysis of cytotoxic lymphocyte function, immune surveillance mechanisms, and host defense processes across a wide range of experimental contexts.
This antibody is part of a broader CD7 antibody collection designed to support T cell biology, immune profiling, and hematologic cancer research.
Optimal dilution of the CD7 Antibody / Cytotoxic Lymphocyte Marker Antibody should be determined by the researcher.
A recombinant partial protein sequence (within amino acids 1-200) from the human protein was used as the immunogen for the CD7 antibody.
Aliquot the CD7 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
CD7 cytotoxic lymphocyte antibody, CD7 effector cell marker antibody, CD7 NK T cell antibody, T-cell antigen CD7 antibody, CD7 immune effector antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.